- Which of the following is the most critical initial action?
Answer: Immediately check a serum creatine kinase (CK) and basic metabolic panel.
The combination of severe myalgias and dark urine is highly suggestive of rhabdomyolysis, a serious adverse effect of statin therapy where muscle breakdown releases myoglobin, causing kidney damage. The most critical initial action is to confirm the diagnosis by checking a serum CK level (which will be markedly elevated) and assess for acute kidney injury by checking a basic metabolic panel (creatinine, BUN, electrolytes).
- Which of the following is the most appropriate advice for this patient?
Answer: Restart paroxetine at the previous dose and schedule an appointment to create a gradual tapering plan.
When you encounter a patient who abruptly stopped an SSRI and is experiencing neurological symptoms, think discontinuation syndrome. This is a well-recognized clinical phenomenon that occurs when patients suddenly stop antidepressants, particularly those with shorter half-lives like paroxetine.
The patient's symptoms—dizziness, fatigue, nausea, and characteristic "brain zaps"—are classic signs of SSRI discontinuation syndrome. These "electric shock" sensations are pathognomonic (uniquely characteristic) of this condition and occur due to sudden drops in serotonin levels when the medication is abruptly withdrawn. Paroxetine has a particularly short half-life and high receptor affinity, making discontinuation syndrome more likely and severe.
Choice D is correct because restarting paroxetine will rapidly alleviate these symptoms by restoring serotonin levels, followed by a proper taper to prevent recurrence. This is the standard medical approach.
Choice A misinterprets the symptoms as neurological emergency signs. While TIA can cause dizziness, the constellation of symptoms plus the medication history points clearly to discontinuation syndrome, not stroke.
Choice B treats only one symptom and ignores the underlying cause. Meclizine won't address the serotonin-related etiology, and waiting could worsen symptoms.
Choice C misattributes these physical symptoms to psychological anxiety. While the patient has panic disorder, these are medication-related physiological effects, not anxiety manifestations.
Study tip: Remember the "brain zaps" as a red flag for SSRI discontinuation syndrome—this symptom is virtually diagnostic and should immediately trigger thoughts of medication withdrawal rather than other neurological conditions.
- A 28-year-old patient is started on clozapine for treatment-resistant schizophrenia. Three weeks into treatment, before reaching the target dose, the patient complains of sudden-onset shortness of breath, chest pain, and fever. An ECG is unremarkable except for sinus tachycardia. Lungs are clear to auscultation. What is the most important initial diagnostic test to order?
Answer: Serum troponin and C-reactive protein (CRP).
While agranulocytosis is the most well-known adverse effect of clozapine, myocarditis is a rare but potentially fatal complication that typically occurs within the first month of treatment. The presentation of chest pain, dyspnea, fever, and tachycardia is highly suspicious for myocarditis. The priority is to investigate this cardiac complication by checking cardiac enzymes (troponin) and inflammatory markers (CRP). The ANC is crucial for long-term monitoring but does not address these acute cardiopulmonary symptoms. A V/Q scan would assess for pulmonary embolism, which is less likely than myocarditis in this specific context.
- What is the nurse's priority action?
Answer: Hold the next dose of gentamicin and notify the prescribing provider.
The significant rise in serum creatinine and decrease in urine output (oliguria) are clear signs of acute kidney injury, a well-known adverse effect of aminoglycosides like gentamicin (nephrotoxicity). The priority action is to prevent further renal damage by holding the next dose of the offending drug and immediately notifying the provider, who can then reassess the treatment plan.
- What is the most appropriate next step in the management of this patient?
Answer: Hold the next dose of lithium and initiate aggressive intravenous hydration.
The patient's clinical presentation (confusion, ataxia, coarse tremor) and serum level (2.2 mEq/L) are indicative of moderate to severe lithium toxicity, which is a medical emergency. The immediate priorities are to stop the offending agent and enhance its elimination. Intravenous hydration with normal saline promotes renal excretion of lithium. For severe cases, hemodialysis may be required.
- A patient with severe rheumatoid arthritis receiving weekly low-dose oral methotrexate presents with significant fatigue, painful oral ulcers, and widespread petechiae. A CBC confirms pancytopenia with a platelet count of 25,000/mm³. Which of the following is the most appropriate pharmacologic intervention?
Answer: Initiate leucovorin rescue therapy.
The patient is experiencing methotrexate toxicity, leading to severe myelosuppression (pancytopenia) and mucositis. Methotrexate works by inhibiting dihydrofolate reductase. The specific antidote is leucovorin (folinic acid), which is a reduced form of folate that can bypass this enzymatic block and allow for DNA synthesis in healthy cells. Standard folic acid is not sufficient for rescue in acute toxicity. Filgrastim addresses only neutropenia, and prednisone is not the primary treatment for methotrexate toxicity.
- Which order is most important for the provider to write regarding the patient's metformin?
Answer: Hold metformin today and for 48 hours post-procedure.
When you encounter a diabetes patient receiving iodinated contrast media, immediately think about contrast-induced nephropathy (CIN) and metformin's potential for causing lactic acidosis. This scenario tests your understanding of drug safety protocols around procedures that can compromise kidney function.
Metformin must be held before contrast procedures because iodinated contrast can cause acute kidney injury, which impairs metformin elimination. When metformin accumulates in patients with reduced kidney function, it can cause potentially fatal lactic acidosis. The standard protocol is to hold metformin at least 48 hours before the procedure and restart only after confirming stable kidney function post-procedure. This patient's elevated creatinine (1.6 mg/dL) and heart failure further increase his CIN risk, making metformin cessation even more critical.
Option A correctly follows evidence-based guidelines for metformin management around contrast procedures. Option B is dangerous because it ignores the lactic acidosis risk - short-term hyperglycemia is far safer than potential lactic acidosis. Option C (dose reduction) doesn't eliminate the risk since any amount of metformin can accumulate if kidney function deteriorates. Option D shows a common misconception - while N-acetylcysteine was once thought to prevent CIN, recent evidence shows it's ineffective, and continuing metformin remains risky regardless.
Remember this pattern: metformin + contrast media = automatic hold for 48+ hours. The risk of lactic acidosis always outweighs short-term glycemic concerns. Look for this safety protocol on any exam question involving metformin and procedures using iodinated contrast.
- Which of the following interventions is the highest priority for this patient?
Answer: Prepare for immediate airway management.
The patient is presenting with classic signs of angioedema, a rare but life-threatening adverse effect of ACE inhibitors like lisinopril. The swelling can rapidly progress to compromise the airway. Therefore, the highest priority is to prepare for potential intubation or cricothyrotomy to secure the airway, following the ABCs (Airway, Breathing, Circulation) of resuscitation.
- What is the most likely cause of her worsening respiratory symptoms?
Answer: Pharmacological blockade of pulmonary beta-2 adrenergic receptors.
Propranolol is a non-selective beta-blocker, meaning it blocks both beta-1 receptors (in the heart) and beta-2 receptors. Beta-2 receptors are found in the lungs, and their stimulation causes bronchodilation. By blocking these receptors, propranolol can cause bronchoconstriction and precipitate an asthma exacerbation. Non-selective beta-blockers are relatively contraindicated in patients with asthma.
- Which of the following is the most appropriate first step in evaluating this patient's symptoms?
Answer: Check a serum digoxin level and a serum potassium level.
The patient's symptoms, including GI distress (nausea, anorexia) and classic visual disturbances (xanthopsia), are highly suggestive of digoxin toxicity. Her advanced age and chronic kidney disease significantly increase her risk due to decreased drug clearance. The most appropriate first step is to confirm the diagnosis by checking a serum digoxin level and also checking the serum potassium, as hypokalemia potentiates digoxin's toxic effects.
- Which intervention should be implemented first?
Answer: Discontinue both sertraline and tramadol immediately.
This patient's presentation is classic for serotonin syndrome, a potentially life-threatening condition caused by excessive serotonergic activity. The combination of an SSRI (sertraline) and tramadol (which also inhibits serotonin reuptake) is a common precipitant. The absolute first step in management is to remove the offending agents.
- What is the most appropriate initial action by the nurse?
Answer: Slow the infusion rate and continue to monitor the patient closely.
When you encounter a patient experiencing adverse reactions during drug infusion, your priority is distinguishing between mild infusion-related reactions and true anaphylaxis, as this determines the urgency and type of intervention needed.
This patient is experiencing "red man syndrome," a common non-allergic reaction to vancomycin caused by rapid histamine release. The key clues are the characteristic flushing pattern (face, neck, upper chest), itching, mild hypotension, and notably the absence of respiratory symptoms. This is a rate-dependent reaction, not a true allergic response.
Choice A is correct because slowing the infusion rate is the standard first-line management for red man syndrome. This allows continued treatment while minimizing the reaction, as the syndrome is directly related to infusion speed rather than the drug itself.
Choice B is wrong because this isn't anaphylaxis - the patient has no respiratory distress, and the hypotension is mild. Epinephrine would be excessive and potentially harmful for a non-allergic reaction.
Choice C is incorrect as the initial action. While antihistamines like diphenhydramine may be used adjunctively, the priority is addressing the cause (rapid infusion) rather than just treating symptoms.
Choice D is wrong because discontinuing vancomycin entirely is unnecessary. Red man syndrome doesn't contraindicate future vancomycin use - it just requires slower administration rates.
Remember: Red man syndrome presents with flushing and mild hypotension but lacks the respiratory compromise seen in anaphylaxis. Always assess for breathing difficulties to distinguish between these two very different clinical scenarios requiring different management approaches.
- A patient with cystic fibrosis is on a 2-week course of intravenous amikacin for a pulmonary exacerbation. The patient reports new-onset, persistent high-pitched ringing in their ears and a sensation that the room is spinning. Which action is the priority?
Answer: Hold the next dose of amikacin and notify the primary medical team immediately.
The patient is describing tinnitus (cochlear toxicity) and vertigo (vestibular toxicity), which are signs of aminoglycoside-induced ototoxicity. This damage can be irreversible and progress even after the drug is stopped. The priority is to prevent further damage by holding the next dose and immediately notifying the provider. While drug levels are important for monitoring, the presence of clear toxic symptoms warrants immediate cessation pending further evaluation. Symptomatic treatment is secondary and reassurance is inappropriate as the damage can be permanent.
- A 45-year-old patient with treatment-resistant schizophrenia, managed with clozapine for the past 6 months, presents with a sudden onset of sore throat, fever of 38.9°C (102°F), and malaise. A STAT complete blood count reveals a white blood cell count of 1,200/mm³ and an absolute neutrophil count (ANC) of 450/mm³. Which of the following is the priority intervention?
Answer: Immediately withhold the next dose of clozapine and initiate protective isolation.
The patient's presentation of fever and sore throat, combined with an ANC < 500/mm³, is indicative of clozapine-induced agranulocytosis, a life-threatening medical emergency. The absolute priority is to immediately discontinue the offending agent (clozapine) to prevent further bone marrow suppression. Initiating protective (reverse) isolation is crucial to prevent opportunistic infections. While antibiotics and G-CSF are important subsequent steps, they do not take precedence over removing the cause of the neutropenia.
- A 9-year-old child being treated with valproic acid for epilepsy is brought to the emergency department with a 2-day history of lethargy, persistent vomiting, and severe, boring epigastric pain that radiates to the back. Which laboratory test should be prioritized to investigate the likely cause of these symptoms?
Answer: Serum lipase and amylase.
The clinical presentation of severe epigastric pain radiating to the back accompanied by vomiting is a classic sign of acute pancreatitis, a rare but life-threatening adverse effect of valproic acid, particularly in children. The most direct and sensitive laboratory tests to diagnose pancreatitis are serum lipase and amylase. While hepatotoxicity (checked by LFTs) and thrombocytopenia (checked by CBC) are also known side effects, the specific symptoms point directly toward pancreatitis, making lipase and amylase the priority.
- A 34-year-old patient with bipolar I disorder is brought to the emergency department with confusion, severe ataxia, and coarse hand tremors. A stat serum lithium level is 2.8 mEq/L (therapeutic range 0.6-1.2 mEq/L). The patient is given a 2L bolus of 0.9% sodium chloride. Despite this, their neurological symptoms worsen over the next hour. What is the most appropriate next intervention?
Answer: Arrange for urgent intermittent hemodialysis.
This patient is presenting with severe lithium toxicity (level > 2.5 mEq/L) and significant, worsening neurological symptoms. While IV fluids are a first step, they are insufficient for severe toxicity. Hemodialysis is the definitive treatment as it effectively removes lithium from the body and is indicated for severe toxicity, especially with prominent neurologic signs. Sodium polystyrene sulfonate is for hyperkalemia, N-acetylcysteine is for acetaminophen toxicity, and lorazepam would only manage symptoms without addressing the underlying cause.
- Which of the following is the most appropriate immediate intervention?
Answer: Administer 5 mg of oral vitamin K.
An INR of >9.0 represents a critically high level of anticoagulation, placing the patient at extreme risk for bleeding, especially after head trauma. In a non-bleeding patient, guidelines recommend holding warfarin and administering oral vitamin K to rapidly but controllably reverse the anticoagulation. This lowers the INR over 24-48 hours, mitigating the high risk of hemorrhage.
- A 75-year-old, opioid-naïve patient with end-stage renal disease is given 3 mg of intravenous morphine for acute pain. Twenty minutes later, the nurse finds the patient somnolent with a respiratory rate of 7 breaths per minute and pinpoint pupils. The patient's oxygen saturation is 86% on room air. After calling for assistance, what is the nurse's immediate priority action?
Answer: Administer naloxone and provide manual ventilation.
The patient is experiencing severe opioid-induced respiratory depression, which is exacerbated by renal failure (due to accumulation of active morphine metabolites). The immediate, life-saving intervention is to reverse the opioid effect with naloxone and support the patient's breathing, likely with a bag-valve-mask, until the naloxone takes effect and spontaneous respiration improves. While stimulation and supplemental oxygen are important, they are insufficient to correct severe hypoventilation. The priority is to reverse the cause and assist ventilation.
- A patient stabilized on long-term paroxetine for depression is admitted for a complicated skin infection and started on intravenous linezolid. On the third day of therapy, the patient becomes acutely agitated and confused. Examination reveals diaphoresis, resting tremor, hyperreflexia, and inducible clonus in the lower extremities. Vital signs are: Temp 39.2°C (102.6°F), HR 125 bpm, BP 160/95 mmHg. What is the priority intervention?
Answer: Discontinue both paroxetine and linezolid and provide supportive care.
This patient is exhibiting classic signs of serotonin syndrome, a potentially life-threatening condition caused by excess serotonergic activity. The combination of an SSRI (paroxetine) and linezolid (which has MAOI properties) is a well-known interaction that precipitates this syndrome. The cornerstone of management is immediate discontinuation of all serotonergic agents. Supportive care (IV fluids, benzodiazepines, cooling) is crucial, but removing the offending drugs is the absolute priority. The other options only address symptoms or delay definitive action.
- What is the most appropriate management decision at this time?
Answer: Hold methotrexate and investigate for other causes of liver injury.
Methotrexate is a known hepatotoxin. A significant elevation in liver transaminases (typically >3 times the upper limit of normal) necessitates immediate discontinuation of the drug to prevent further, potentially irreversible, liver damage. Once the drug is held, other potential causes of liver injury should be considered, though methotrexate is the most likely culprit.
